HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas W Laske Selected Research

131I-chimeric TNT-1-B monoclonal antibody

6/2005Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas W Laske Research Topics

Disease

2Neoplasms (Cancer)
06/2005 - 10/2003
2Glioma (Gliomas)
06/2005 - 10/2003
1Headache (Headaches)
06/2005
1Paresis (Hemiparesis)
06/2005
1Brain Edema (Cerebral Edema)
06/2005
1Brain Neoplasms (Brain Tumor)
10/2003

Drug/Important Bio-Agent (IBA)

1131I-chimeric TNT-1-B monoclonal antibodyIBA
06/2005
1Pharmaceutical PreparationsIBA
06/2005
1Immunotoxins (Immunotoxin)IBA
10/2003
1LigandsIBA
10/2003
1Transferrin Receptors (Transferrin Receptor)IBA
10/2003
1Tf-CRM107IBA
10/2003

Therapy/Procedure

1Catheters
10/2003
1Therapeutics
10/2003